BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29188529)

  • 1. Spinal ependymomas in NF2: a surgical disease?
    Kalamarides M; Essayed W; Lejeune JP; Aboukais R; Sterkers O; Bernardeschi D; Peyre M; Lloyd SK; Freeman S; Hammerbeck-Ward C; Kellett M; Rutherford SA; Evans DG; Pathmanaban O; King AT
    J Neurooncol; 2018 Feb; 136(3):605-611. PubMed ID: 29188529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2.
    Farschtschi S; Merker VL; Wolf D; Schuhmann M; Blakeley J; Plotkin SR; Hagel C; Mautner VF
    Acta Neurol Scand; 2016 Jun; 133(6):475-80. PubMed ID: 26369495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal ependymomas. Part 1: Intramedullary ependymomas.
    Klekamp J
    Neurosurg Focus; 2015 Aug; 39(2):E6. PubMed ID: 26235023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord ependymomas in children and adolescents.
    Benesch M; Frappaz D; Massimino M
    Childs Nerv Syst; 2012 Dec; 28(12):2017-28. PubMed ID: 22961356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2.
    J Neurosurg Spine; 2017 Apr; 26(4):474-482. PubMed ID: 27982762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.
    Plotkin SR; O'Donnell CC; Curry WT; Bove CM; MacCollin M; Nunes FP
    J Neurosurg Spine; 2011 Apr; 14(4):543-7. PubMed ID: 21294614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
    Hagel C; Stemmer-Rachamimov AO; Bornemann A; Schuhmann M; Nagel C; Huson S; Evans DG; Plotkin S; Matthies C; Kluwe L; Mautner VF
    Neuropathology; 2012 Dec; 32(6):611-6. PubMed ID: 22394059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case.
    Snyder MH; Ampie L; DiDomenico JD; Asthagiri AR
    J Clin Neurosci; 2021 Apr; 86():79-84. PubMed ID: 33775351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment.
    Behmanesh B; Gessler F; Dützmann S; Dubinski D; Imoehl L; Seifert V; Setzer M; Marquardt G
    J Neurooncol; 2017 Oct; 135(1):93-98. PubMed ID: 28667596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intramedullary ependymomas: A French retrospective multicenter study of 221 cases].
    Aghakhani N; Messerer M; David P; Herbrecht A; Parker F
    Neurochirurgie; 2017 Nov; 63(5):391-397. PubMed ID: 28162253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lower cranial nerve schwannoma with spinal ependymoma in ? NF2.
    Kumar R; Sharma KH; Chhabra DK
    Neurol India; 1999 Jun; 47(2):145-7. PubMed ID: 10447465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal ependymomas. Part 2: Ependymomas of the filum terminale.
    Klekamp J
    Neurosurg Focus; 2015 Aug; 39(2):E7. PubMed ID: 26235024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ependymoma of the Spinal Cord in Children: A Retrospective French Study.
    Szathmari A; Zerah M; Vinchon M; Dufour C; Gimbert E; Di Rocco F; Chabaud S; Conter C; Mottolese C; Frappaz D
    World Neurosurg; 2019 Jun; 126():e1035-e1041. PubMed ID: 30877001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal tanycytic ependymoma associated with neurofibromatosis type 2--case report.
    Ueki K; Sasaki T; Ishida T; Kirino T
    Neurol Med Chir (Tokyo); 2001 Oct; 41(10):513-6. PubMed ID: 11760389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of spinal tumors in neurofibromatosis type 2 patients.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
    Neurol Neurochir Pol; 2016; 50(1):31-5. PubMed ID: 26851687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of primary spinal ependymomas: a single center experience from Taiwan.
    Huang YH; Lin JW
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2130-5. PubMed ID: 23988347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
    Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
    Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.